Company / Share Buybacks
Charles River Laboratories Share Buybacks History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Share Buybacks
$360.7M
FY2025
5-year range
$18.1M / $360.7M
FY2021-FY2025
Trend
+202.6%
vs FY2024
Sector context
#35 of 101
Health Care
What the data says
Share Buybacks changed +203% YoY in FY2025, a notable deviation from the 9-year average annual change of +200%.
Based on SEC 10-K filings.
$361M in FY2025 with a 5-year CAGR of +91.9%.
Improved from $41M to $361M over the past 2 years.
Health Care sector context is included.
Share Buybacks over time
Growth rates
- 3-Year CAGR
- +146.8%
- 5-Year CAGR
- +91.9%
- 10-Year CAGR
- -
Sector benchmark
#35 of 101 in Health CareTop 35% of 101This company $360.7M Sector average $570.7M
▼
-36.8% below sector average
Key checks
Key Insights
- Charles River Laboratories's share buybacks has grown for 5 consecutive years.
- 5-year CAGR of +91.9%, indicating consistent growth.
- In FY2025, share buybacks increased 202.6% year-over-year.
- Ranks #35 out of 101 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Share BuybacksValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $360.7M | +202.6% |
| FY2024 | $119.2M | +192.8% |
| FY2023 | $40.7M | +69.8% |
| FY2022 | $24.0M | +32.6% |
| FY2021 | $18.1M | +30.6% |
| FY2020 | $13.8M | -87.0% |
| FY2019 | $106.9M | +672.1% |
| FY2018 | $13.8M | -87.0% |
| FY2017 | $106.9M | +771.5% |
| FY2016 | $12.3M | -92.6% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026